Entero Therapeutics Inc (ENTO) concluded trading on Wednesday at a closing price of $0.55, with 20.98 million shares of worth about $11.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -11.48% during that period and on July 09, 2025 the price saw a gain of about 3.53%. Currently the company’s common shares owned by public are about 4.77M shares, out of which, 4.44M shares are available for trading.
Stock saw a price change of 40.54% in past 5 days and over the past one month there was a price change of 5.54%. Year-to-date (YTD), ENTO shares are showing a performance of -48.71% which decreased to -11.77% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $1.27 during that period. The average intraday trading volume for Entero Therapeutics Inc shares is 1.30 million. The stock is currently trading 15.37% above its 20-day simple moving average (SMA20), while that difference is up 25.63% for SMA50 and it goes to 9.89% higher than SMA200.
Entero Therapeutics Inc (NASDAQ: ENTO) currently have 4.77M outstanding shares and institutions hold larger chunk of about 2.97% of that.
The stock has a current market capitalization of $2.62M and its 3Y-monthly beta is at 0.76. It has posted earnings per share of -$7.32 in the same period. It has Quick Ratio of 2.90 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ENTO, volatility over the week remained 17.91% while standing at 15.56% over the month.
